Additionally, DMAMCL has been reported to alleviate NLRP3-mediated neuroinflammation, potentially inhibiting the progression of Parkinson’s disease (PD) by modulating the NLRP3 inflammasome (Liu et al., 2020b). This evidence concerns the gene NLRP3 and Parkinson disease.